New Key Statistics Module, Z-Score and F-Score
XCNQ:CURE Key Ratios
Market Cap C$ M | 1.41 |
Enterprise Value C$ M | 1.49 |
P/E(ttm) | -- |
PE Ratio without NRI | 3.00 |
Forward PE Ratio | -- |
Price/Book | 0.88 |
Price/Sales | -- |
Price/Free Cash Flow | 15.00 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.01 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 35.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.04 |
EV-to-EBITDA | -1.04 |
PEG | 0.09 |
Shares Outstanding M | 94.00 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 0.04 |
Current Ratio | 0.04 |
ROA % (ttm) | -58.19 |
ROE % (ttm) | -122.27 |
ROIC % (ttm) | -34.89 |
Dividend Yield % | -- |
Altman Z-Score | -- |
XCNQ:CURE Number of Guru Trades
XCNQ:CURE Volume of Guru Trades
Gurus Latest Trades with XCNQ:CURE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:CURE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biocure Technology Inc Insider Transactions
No Available Data